Advanced Microparticulate/Nanoparticulate Respirable Dry Powders of a Selective RhoA/Rho Kinase (Rock) Inhibitor for Targeted Pulmonary Inhalation Aerosol Delivery is a research paper published in Pharmaceutics (2021). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01HL137282,R01HL60190,R21AG054766,R21AI135935,P01HL103453
NIA NIH HHS
Grant: R21 AG054766
NHLBI NIH HHS
Grant: P01 HL134610
NHLBI NIH HHS
Grant: P01 HL103453
NHLBI NIH HHS
Grant: P01 HL146369
NHLBI NIH HHS
Grant: R01 HL137282
NHLBI NIH HHS
Grant: R01 HL142212
NHLBI NIH HHS
Grant: R01 HL060190
NIAID NIH HHS
Grant: R21 AI135935
National Science Foundation
Grant: 0619599
MRI: Acquisition of a Renishaw Structural and Chemical Analyzer and a Field-Emission Scanning Electron Microscope
National Institutes of Health
Grant: 5P01HL146369-02
Administrative Core
National Institutes of Health
Grant: 5P01HL103453-09
Asthma Inflammation Research
National Institutes of Health
Grant: 5R01HL137282-02
Perinatal NO signaling in congenital heart disease
National Institutes of Health
Grant: 5R21AG054766-02
Preclinical development of a novel Nrf2-activator formulation for the treatment of idiopathic pulmonary fibrosis
National Institutes of Health
Grant: 2R01HL060190-11A1
Perinatal Regulation of Endothelial NOS
National Institutes of Health
Grant: 5R21AI135935-02
Surfactant Protein A as a Novel Therapeutic for Asthma
National Institutes of Health
Grant: 5P01HL134610-06
Genetics, Epigenetics, and Post-translational Modifications and the Development of Ventilator Induced Lung Injury (VILI)
FWCI
0.78
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals